Tin tức & Cập nhật

MS patients on certain DMTs may have limited protection from COVID-19 vax
MS patients on certain DMTs may have limited protection from COVID-19 vax
30 May 2022 bởiRoshini Claire Anthony

The overall rate of hospitalization for COVID-19 is low among patients with multiple sclerosis (MS) treated with disease-modifying therapies (DMTs) who have been vaccinated against COVID-19, according to a prospective study from England. However, patients on ocrelizumab or fingolimod have elevated hospitalization rates.

MS patients on certain DMTs may have limited protection from COVID-19 vax
30 May 2022